We are excited to announce our participation in the Society for Neuroscience (SfN) Congress taking place in Chicago from October 5-9, 2024. This premier event brings together industry experts and researchers from around the globe to explore the latest advancements in neuroscience.
Our CEO, Bernard van Iseghem, and CBO, Yassine Darbaky, will be attending the event to connect with industry experts, share insights, and explore new opportunities in the field of analgesic drug development.
They look forward to engaging with fellow professionals and discussing the latest advancements in pain management research. If you are attending the congress and would like to arrange a meeting with our team, please reach out to us to schedule a convenient time.
Yassine and Bernard can’t wait to see you in Chicago and explore potential collaborations to advance pain management solutions together.
A heartfelt thank you to the Auvergne-Rhône-Alpes region for their support, which made our participation in this key event possible. ✨
